Shelton Capital Management Emergent Bio Solutions Inc. Transaction History

Shelton Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$81.91 - $134.94 $257,443 - $424,116	-3,143 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $170,759 - $281,361	3,143 New	3,143 $249,000
Q1 2020 May 13, 2020	SELL	$49.34 - $68.76 $193,511 - $269,676	-3,922 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$51.21 - $59.06 $26,321 - $30,356	-514 Reduced 11.59%	3,922 $212,000
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $168,143 - $226,858	4,212 Added 1880.36%	4,436 $214,000
Q1 2019 May 10, 2019	SELL	$48.23 - $66.16 $203,144 - $278,665	-4,212 Reduced 94.95%	224 $4.44 Million
Q4 2018 Jan 31, 2019	BUY	$55.63 - $73.24 $49,343 - $64,963	887 Added 24.99%	4,436 $263,000
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $184,725 - $236,043	3,549 New	3,549 $234,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.